Elena Lukina

3.2k total citations
79 papers, 1.8k citations indexed

About

Elena Lukina is a scholar working on Physiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Elena Lukina has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Physiology, 26 papers in Organic Chemistry and 25 papers in Molecular Biology. Recurrent topics in Elena Lukina's work include Lysosomal Storage Disorders Research (52 papers), Carbohydrate Chemistry and Synthesis (26 papers) and Glycosylation and Glycoproteins Research (18 papers). Elena Lukina is often cited by papers focused on Lysosomal Storage Disorders Research (52 papers), Carbohydrate Chemistry and Synthesis (26 papers) and Glycosylation and Glycoproteins Research (18 papers). Elena Lukina collaborates with scholars based in Russia, United States and Israel. Elena Lukina's co-authors include Nora Watman, Hanna Rosenbaum, Michel Peterschmitt, Ana Cristina Puga, Kenneth L. McClain, Cesare Danesino, Maurizio Aricò, Nicole Grois, Gregory M. Pastores and Catherine Klersy and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Elena Lukina

68 papers receiving 1.8k citations

Peers

Countries citing papers authored by Elena Lukina

Since Specialization

Citations

This map shows the geographic impact of Elena Lukina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Lukina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Lukina more than expected).

Fields of papers citing papers by Elena Lukina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Lukina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Lukina. The network helps show where Elena Lukina may publish in the future.

Co-authorship network of co-authors of Elena Lukina

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Lukina. A scholar is included among the top collaborators of Elena Lukina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Lukina. Elena Lukina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease 2025 ·Terapevticheskii arkhiv ·Elena Lukina, (unknown), (unknown), (unknown), (unknown), И. Л. Давыдкин, (unknown), Tatiana Shelekhova, Marina Kosinova, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria 2024 ·Acta Haematologica ·Alexander Kulagin, В. В. Птушкин, Elena Lukina, И. Л. Давыдкин, (unknown), Т. С. Константинова, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice 2024 ·SHILAP Revista de lepidopterología ·Н. Г. Мокрышева, М. В. Шестакова, Ametov As, М. Б. Анциферов, И. Г. Бакулин, Т. В. Вавилова, G. R. Galstyan, (unknown), (unknown), Т. Л. Каронова, Elena Lukina, А. M. Mkrtumyan, Н. А. Петунина, (unknown), Н. А. Супонева, O. Yu. Sukhareva, Минара Шамхаловна Шамхалова	1
4	Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry 2024 ·Journal of Clinical Medicine ·Deborah Elstein, Nadia Belmatoug, Bruno Bembi, Patrick Deegan, (unknown), Pilar Giraldo, Özlem Göker-Alpan, Derralynn Hughes, Heather Lau, Elena Lukina, Shoshana Revel‐Vilk, Ida Vanessa Döederlein Schwartz, (unknown), Jaco Botha, Noga Gadir, (unknown), Ari Zimran	2
5	Extrahepatic portal hypertension in myeloproliferative diseases, features of diagnosis and therapeutic tactics 2024 ·Endoscopic Surgery ·(unknown), Elena Lukina, (unknown), (unknown)	0
6	Hematological response in patients with paroxysmal nocturnal hemoglobinuria treated with C5-inhibitor 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Elena Lukina, Е. Н. Паровичникова	0
7	Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations 2023 ·Advances in Therapy ·Imre Bodó, (unknown), Ana Boban, Horia Bumbea, Alexander Kulagin, Elena Lukina, Agnieszka Piekarska, (unknown), Juraj Sokol, Jerzy Windyga, Jaroslav Čermák	9
8	Autoimmune hemolytic anemia: the current state of the issue 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Elena Lukina	0
9	Modern view on treatment of iron and folic acid deficiency 2023 ·Russian Journal of Preventive Medicine ·Martynov Ai, Elena Lukina, (unknown), О. Д. Остроумова, Е. В. Ших, (unknown), (unknown), (unknown)	1
10	Clinical guidelines for the management of patients with paroxysmal nocturnal hemoglobinuria 2022 ·Savchenko Vg, Elena Lukina, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), В. В. Птушкин, Boris V. Afanasyev, Alexander Kulagin, (unknown), Alexey Maschan, Н.С. Сметанина, (unknown)	2
11	Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: Phase 3 ENGAGE trial final results 2021 ·American Journal of Hematology ·Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, Suma P. Shankar, Hagit Baris Feldman, Marwan Ghosn, Atul Mehta, Seymour Packman, Heather Lau, Мilan Petakov, Sarit Assouline, Manisha Balwani, Sumita Danda, Evgueniy Hadjiev, Andres Ortega, Meredith C. Foster, Sebastiaan J.M. Gaemers, Michel Peterschmitt	31
12	Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab 2021 ·Annals of Hematology ·Alexander Kulagin, В. В. Птушкин, Elena Lukina, И. Л. Давыдкин, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), D.А. Kudlаy	19
13	Gaucher disease: achievements and prospects 2021 ·Terapevticheskii arkhiv ·(unknown), Elena Lukina	2
14	The non-compacted myocardium in patients with hemochromatosis: a phenomenon or cardiopathy? The role of magnetic resonance imaging and molecular genetics in diagnosis 2020 ·SHILAP Revista de lepidopterología ·Е. А. Мершина, (unknown), R. P. Myasnikov, Elena Lukina, А. Н. Мешков, А. В. Киселева, (unknown), (unknown), М. С. Харлап, (unknown), (unknown), (unknown), S. А. Boytsov, В. Е. Синицын, О. М. Драпкина	1
15	Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy 2020 ·SHILAP Revista de lepidopterología ·В. В. Птушкин, Alexander Kulagin, Elena Lukina, И. Л. Давыдкин, Т. С. Константинова, (unknown), (unknown), D.А. Kudlаy, (unknown), (unknown), (unknown)	15
16	REDUCED DOSING REGIMEN OF ENZYME REPLACEMENT THERAPY IN ADULT PATIENTS WITH TYPE I GAUCHER DISEASE: PRELIMINARY RESULTS 2019 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), С. М. Куликов, Elena Lukina	3
17	REVERSIBLE AND IRREVERSIBLE RADIOLOGICAL SIGNS OF BONE INVOLVEMENT IN TYPE I GAUCHER DISEASE 2019 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Elena Lukina	0
18	MAGNETIC RESONANCE IMAGING OF THE LIVER AND SPLEEN IN THE DIAGNOSIS OF STORAGE DISEASES (literature review) 2018 ·Oncohematology ·(unknown), (unknown), (unknown), Elena Lukina	0
19	Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial 2018 ·American Journal of Hematology ·Elena Lukina, Nora Watman, Marta Dragosky, Heather Lau, Elsa Ávila Arreguin, Hanna Rosenbaum, Ari Zimran, Meredith C. Foster, Sebastiaan J.M. Gaemers, Michel Peterschmitt	49
20	Encore: A Randomized, Controlled, Open-Label Non-Inferiority Study Comparing Eliglustat To Imiglucerase In Gaucher Disease Type 1 Patients On Enzyme Replacement Therapy Who Have Reached Therapeutic Goals 2013 ·Blood ·Manisha Balwani, Timothy M. Cox, Guillermo Drelichman, (unknown), Ana María Martins, Elena Lukina, Barry E. Rosenbloom, Leorah Ross, Jennifer Angell, Ana Cristina Puga	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact